According to a White House issued fact sheet on Monday July 28th, 2025, all pharmaceutical imports from EU to US will be subject to a baseline 15% tariff. On this Tuesday August 5th, 2025, Trump administration has reassessed on imported pharmaceutical products and says the tariffs will eventually go up to 250%. The baseline 15% tariff is the initial number. "We'll be putting initially a small tariff on pharmaceuticals, but in one year-one and a half years maximum-it's going to go to 150% and then it's going to go to 250%," according to President Trump during a phone interview with CNBC. The tariff initiative is part of the agenda to revitalize American manufacturing. It is designed to make drug makers to manufacture their products in the United States. As a result, big drug makers such as AstraZeneca, Johnson & Johnson and Novartis have announced significant investment plans in the U.S. for the foreseeable future.
References:
1. Dunleavy, K. (2025, August 5) Trump ups the ante on pharma tariffs, saying they will reach 250%. Fierce Pharma. https://www.fiercepharma.com/pharma/trump-ups-ante-pharma-tariffs-saying-they-will-reach-250
2. Kansteiner, F. (2025, July 29) Trump's pharmaceutical tariffs materialize at last in new US-EU trade deal. Fierce Pharma. https://www.fiercepharma.com/manufacturing/trumps-pharmaceutical-tariffs-materialize-last-new-us-eu-trade-deal
